Amyloidosis trials in Norway

3 of 8 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• No phaseTaking people
  A Study to Learn About the Use of Acoramidis in Patients With a Heart Condition Called Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in a Real-world Setting

  Where

  Multiple Locations

  Age

  18 years and over

  People

  2,000 worldwide

  Run by

  Bayer

  See details and how to joinNCT07235462
• No phaseTaking people
  ATTR Cardiac Amyloidosis in a Selected Population

  Where

  Ålesund

  Age

  50 years and over

  People

  180

  Run by

  Helse Møre og Romsdal HF

  See details and how to joinNCT06458374
• No phaseTaking people
  The Norwegian Immunotherapy in Multiple Myeloma Study

  Where

  Ålesund, Arendal, Bærum, Bergen, Bodø, Drammen, Førde, Gjøvik, Haugesund, Kristiansand, Kristiansund, Levanger, Molde, Nordbyhagen, Oslo, Skien, Stavanger, Tønsberg, Tromsø, Trondheim, Volda

  Age

  18 years and over

  People

  400

  Run by

  St. Olavs Hospital

  See details and how to joinNCT06855121